The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome have?
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome has 27 citations in the OpenAlex counts ScholarIQ stores.
When was The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome published?
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome has 2022 year in the ScholarIQ index.
What is the open-access status of The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome?
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome has gold oa status in the ScholarIQ index.
What is the DOI of The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome?
The DOI for The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome is on the source record.
What is the PMID of The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome?
The PMID for The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome is on the source record.
What is the OpenAlex record for The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome?
The OpenAlex for The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome is on the source record.